Join us for the second webinar on the 7th December.
Moderator Pierre Aumont and the panelists are Prof. Chris Pepper, Prof. Chris Fegan and CLL patient Jan Rynne.
This educational webinar will aim to explain in simple language to a layperson audience the basic science behind BTK targeted therapies in use and study today to treat CLL.
7 December 2022 – CLLAN Webinar on “How are advances in Bruton’s tyrosine kinase targeted therapies continuing to change how chronic lymphocytic leukemia (CLL) is treated?”
18:00 – 19:00 CET / 17:00 – 18:00 GMT / 9:00 – 10:00 PST